Navigation Links
Cognition declines 4 times faster in people with Alzheimer's disease than those with no dementia
Date:3/22/2010

People with Alzheimer's disease experience a rate of cognitive decline four times greater than those with no cognitive impairment according to a new study by researchers at Rush University Medical Center in Chicago. The results of the study, which is only the second population-based study to quantify the rate of cognitive decline in Alzheimer's disease, are published in the March 23, 2010 issue of the journal Neurology, the medical journal of the American Academy of Neurology.

"Knowledge about the progressive cognitive decline in Alzheimer's disease is mainly based on studies of persons evaluated in clinical settings. In such studies, the full spectrum of the disease is unlikely to be represented," said study author Robert S. Wilson, PhD, a neuropsychologist at the Rush Alzheimer's Disease Center. "As a result, it has been difficult to securely determine the cognitive consequences of the disease and to test whether they vary in racial or ethnic subgroups of the population."

Researchers at the Rush Alzheimer's Disease Center and the Rush Institute for Healthy Aging set out to quantify the rates of cognitive decline in people who developed Alzheimer's disease and its precursor, mild cognitive impairment.

The study followed 1,168 older adults. All were participants in the Chicago Health and Aging Project, a longitudinal cohort study of older white and black persons residing on the south side of Chicago. At the beginning of the study, participants did not have dementia. After a mean of five to six years, they had a detailed clinical evaluation and 614 persons were found to have no cognitive impairment, 395 had mild cognitive impairment, and 149 had Alzheimer's disease. They then completed brief cognitive testing at 3-year intervals for a mean of five and half years.

In comparison to the no cognitive impairment group, the annual rate of cognitive decline was increased more than twofold in those with mild cognitive impairment and more than fourfold in those with Alzheimer's disease. The results did not vary by race, sex, or age.

"This study is especially significant because half of the participants are African Americans. Most of what we know about Alzheimer's disease is based on studies of Caucasians," said Wilson. "Our study found no difference in how the disease played out in the two races."

Study authors note that this is one of the few studies to look at a large population without the disease and track the disease progression as it is newly diagnosed. The results were similar to the only other study of its kind, which was completed over a decade ago.

"Part of understanding this disease is carefully quantifying what the consequences are in a defined population," said Wilson. "Such knowledge is especially important now with the prevalence of Alzheimer's disease expected to sharply increase by the middle of the 21st century."


'/>"/>

Contact: Kim Waterman
Kimberly_Waterman@rush.edu
312-942-7820
Rush University Medical Center
Source:Eurekalert

Related medicine news :

1. CareTech Solutions Web Clients Earn Top Recognition in the Tenth Annual eHealthcare Leadership Awards Competition
2. Childrens Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency
3. ILS Technology and Customer ASML Recipients of Industry Recognition Awards
4. The Garlands of Barrington Earns International Recognition, Residents Reap the Benefits of Award-Winning EngAGE Lifestyle
5. Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration
6. Christiana Care Health System Achieves Magnet(R) Recognition
7. Pelosi Statement in Recognition of Women’s History Month
8. Quantros Releases Video in Recognition of National Patient Safety Week
9. Zimmer Receives Recognition for Health Economics Data Presented at 77th Annual American Academy of Orthopaedic Surgeons Meeting
10. Cautious Optimism Begins, Pessimism Declines on U.S. and Global Economies Among U.S. Industrial Manufacturers, According to PricewaterhouseCoopers Q4 2009 Manufacturing Barometer
11. Physician Satisfaction with Electronic Medical Records Declines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... , ... May 06, 2016 , ... ... AsedaSciences® in an upcoming episode, airing third quarter 2016, via Discovery Channel. Dates ... of becoming a leader in optimized drug discovery through innovative cellular analysis. In ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... does to reduce fat areas around the body, is the most popular among ... results just released make perfect sense to cosmetic surgeon Dr. Richard Buckley, medical ...
(Date:5/6/2016)... Grants Pass, OR (PRWEB) , ... May 06, 2016 , ... ... the eyes. In other seasons, when the weather is too cold, dry or hot, ... weather, the eyes can actually absorb moisture from the surrounding air. There’s only one ...
(Date:5/6/2016)... ... May 06, 2016 , ... Online HR/benefits platforms offer a range ... game for traditional brokers and health plans. “ The Rapid Emergence of Online Benefits ... Atlantic Information Services, Inc. (AIS), will offer an accurate picture of online benefits today, ...
(Date:5/6/2016)... ... May 06, 2016 , ... From May 4 to 6, ... members the unique opportunity to learn more about Signia’s technology and the successful business ... “It is our priority to see practices succeed in this highly competitive industry,” said ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... , May 6, 2016 ... of liver disorders along with rise in obesity ... drugs in the coming few years. The NASH ... last five years on account of rising number ... is a large, un-tapped market with no FDA ...
(Date:5/5/2016)... -- Replikins Ltd. today reported initial promising results in animal trials of its Zika vaccine ... ... ... ... on Pubmed. The analysis identified the highest gene Replikin Counts in Zika history back ...
(Date:5/5/2016)...  Endo International plc (NASDAQ: ENDP ... Lortie , President, U.S. Branded Pharmaceuticals, has decided ... appointment of a successor. Mr. Lortie joined Endo ... with responsibility for all strategic, commercial and operational ... development, commercial operations, managed markets, manufacturing, supply chain ...
Breaking Medicine Technology: